BiotechTube

DS-1971 + placebo

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety

Conditions

Safety, Tolerability, Pharmacokinetics

Trial Timeline

Mar 1, 2014 โ†’ Jul 1, 2014

NCT ID
NCT02107885

About DS-1971 + placebo

DS-1971 + placebo is a phase 1 stage product being developed by Daiichi Sankyo for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT02107885. Target conditions include Safety, Tolerability, Pharmacokinetics.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02107885Phase 1Completed

Competing Products

20 competing products in Safety

See all competitors
ProductCompanyStageHype Score
LPH-5 + PlaceboBiotrialPhase 1
25
ASP7962 + PlaceboAstellas PharmaPhase 1
33
ASP2151 + Valacyclovir + PlaceboAstellas PharmaPhase 1
33
AZD7986, oral solution, 1 to 50 mg/mL + Placebo, oral solutionAstraZenecaPhase 1
33
Anifrolumab SC injection (300mg) + Anifrolumab IV infusion (300mg) + Anifrolumab SC infusion (600mg) + Anifrolumab placebo SC injection (300mg) + Anifrolumab placebo IV infusion (300mg) + Anifrolumab placebo SC infusion (600mg)AstraZenecaPhase 1
33
AZD7594 + Placebo to matchAstraZenecaPhase 1
33
Anastrozole ODF + Arimidex tablet + Anastrozole ODF + Arimidex tabletAstraZenecaPhase 1
33
AZD4721 Solution + AZD4721 Placebo + AZD4721 SuspensionAstraZenecaPhase 1
33
AZD9977, oral suspension + Placebo, oral suspension + AZD9977, oral solutionAstraZenecaPhase 1
33
AZD3043AstraZenecaPhase 1
33
AZD8848 + Placebo to match AZD8848AstraZenecaPhase 1
33
AZD9567 Monohydrat + Placebo oral suspension/ Placebo capsule + PrednisoloneAstraZenecaPhase 1
33
AZD7503 + PlaceboAstraZenecaPhase 1
33
Fluad + SalineNovartisApproved
85
TBM100NovartisApproved
85
VIB9600 + PlacebosAmgenPhase 1
32
DenosumabAmgenPhase 3
76
Cadonilimab Combined Albumin-paclitaxel, Cisplatin and FluorouracilAkesoPhase 2
51
HTL0018318 + Placebo oral capsuleNxera PharmaPhase 1
32
Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + PlaceboBayerApproved
82

Other Products from Daiichi Sankyo

Olmesartan medoxomil + Olmesartan medoxomil/hydrochlorothiazide + HydrochlorothiazideApproved
85
OAC aloneApproved
85
olmesartan medoxomil + Placebo + losartan potassiumApproved
85
Prasugrel + ClopidogrelApproved
85
Diet+pravastatinApproved
85